Victrex plc (LON:VCT – Get Free Report) has been assigned an average rating of “Hold” from the six brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is GBX 663.33.
VCT has been the topic of several research analyst reports. Berenberg Bank upped their price objective on Victrex from GBX 600 to GBX 680 and gave the company a “hold” rating in a research note on Wednesday, July 8th. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 595 target price on shares of Victrex in a report on Tuesday, July 7th. Canaccord Genuity Group lowered Victrex to a “buy” rating and set a GBX 725 price objective for the company. in a report on Friday, May 15th. Finally, UBS Group reiterated a “sell” rating and issued a GBX 575 target price on shares of Victrex in a research report on Monday, May 11th.
Get Our Latest Analysis on VCT
Victrex Price Performance
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Further Reading
- Five stocks we like better than Victrex
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
